BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26517508)

  • 21. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
    Hou MF; Chen PM; Chu PY
    BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
    Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
    Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA-34a-5p regulates progression of neuroblastoma via modulating the Wnt/β-catenin signaling pathway by targeting SOX4.
    Wang Y; Guan E; Li D; Sun L
    Medicine (Baltimore); 2021 May; 100(20):e25827. PubMed ID: 34011046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LGR5 interacts and cointernalizes with Wnt receptors to modulate Wnt/β-catenin signaling.
    Carmon KS; Lin Q; Gong X; Thomas A; Liu Q
    Mol Cell Biol; 2012 Jun; 32(11):2054-64. PubMed ID: 22473993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling.
    Carmon KS; Gong X; Lin Q; Thomas A; Liu Q
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11452-7. PubMed ID: 21693646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of LGR5 by H2O2 treatment is associated with cell proliferation via the JNK signaling pathway in colon cancer cells.
    Kim SH; Kim KH; Yoo BC; Ku JL
    Int J Oncol; 2012 Nov; 41(5):1744-50. PubMed ID: 22923033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
    Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
    Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Selective Estrogen Receptor Modulator Raloxifene Regulates Arginine-Vasopressin Gene Expression in Human Female Neuroblastoma Cells Through G Protein-Coupled Estrogen Receptor and ERK Signaling.
    Grassi D; Ghorbanpoor S; Acaz-Fonseca E; Ruiz-Palmero I; Garcia-Segura LM
    Endocrinology; 2015 Oct; 156(10):3706-16. PubMed ID: 26200092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-equivalence of Wnt and R-spondin ligands during Lgr5
    Yan KS; Janda CY; Chang J; Zheng GXY; Larkin KA; Luca VC; Chia LA; Mah AT; Han A; Terry JM; Ootani A; Roelf K; Lee M; Yuan J; Li X; Bolen CR; Wilhelmy J; Davies PS; Ueno H; von Furstenberg RJ; Belgrader P; Ziraldo SB; Ordonez H; Henning SJ; Wong MH; Snyder MP; Weissman IL; Hsueh AJ; Mikkelsen TS; Garcia KC; Kuo CJ
    Nature; 2017 May; 545(7653):238-242. PubMed ID: 28467820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAF1-MEK/ERK pathway-dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation.
    Fujii S; Ishibashi T; Kokura M; Fujimoto T; Matsumoto S; Shidara S; Kurppa KJ; Pape J; Caton J; Morgan PR; Heikinheimo K; Kikuchi A; Jimi E; Kiyoshima T
    J Pathol; 2022 Jan; 256(1):119-133. PubMed ID: 34622442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with β-catenin-dependent and β-catenin-independent signaling pathways.
    Zins K; Schäfer R; Paulus P; Dobler S; Fakhari N; Sioud M; Aharinejad S; Abraham D
    Oncotarget; 2016 Jul; 7(29):46187-46202. PubMed ID: 27323822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation.
    Yun MS; Kim SE; Jeon SH; Lee JS; Choi KY
    J Cell Sci; 2005 Jan; 118(Pt 2):313-22. PubMed ID: 15615777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of N‑Myc inhibits neuroblastoma cell growth via the Wnt/β‑catenin signaling pathway.
    Wang Y; Gao S; Wang W; Xia Y; Liang J
    Mol Med Rep; 2018 Jul; 18(1):377-384. PubMed ID: 29749516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Differentiation of induced pluripotent stem cells into neural stem cells induced by brain-derived neurotrophic factor via Wnt/β-catenin and extracellular signal-regulated kinase/mitogen-activated protein kinases signal pathway].
    Chen SQ; Huang M; Liu CL; Shen YY; Cai Q; Wang PJ
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(41):3263-3268. PubMed ID: 29141367
    [No Abstract]   [Full Text] [Related]  

  • 35. LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/β-catenin pathway.
    Shi S; Chen X; Liu H; Yu K; Bao Y; Chai J; Gao H; Zou L
    Gene; 2019 Jan; 683():47-53. PubMed ID: 30300682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PI3K/Akt and Wnt/β-catenin Signaling Cross-regulate NF-κB Signaling in TNF-α-induced Human Lgr5
    Zhao X; Ma B; Zhu H; Bai J; Liu L; Li X; Cai J; Wang B; Wang L; Pang Y; Zhang H; Yang YI; Li N; Chen M
    Anticancer Res; 2022 Jul; 42(7):3325-3340. PubMed ID: 35790295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated Expression of LGR5 and WNT Signaling Factors in Neuroblastoma Cells With Acquired Drug Resistance.
    Clark-Corrigall J; Myssina S; Michaelis M; Cinatl J; Ahmed S; Carr-Wilkinson J
    Cancer Invest; 2023 Feb; 41(2):173-182. PubMed ID: 36318235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells.
    Fafilek B; Krausova M; Vojtechova M; Pospichalova V; Tumova L; Sloncova E; Huranova M; Stancikova J; Hlavata A; Svec J; Sedlacek R; Luksan O; Oliverius M; Voska L; Jirsa M; Paces J; Kolar M; Krivjanska M; Klimesova K; Tlaskalova-Hogenova H; Korinek V
    Gastroenterology; 2013 Feb; 144(2):381-391. PubMed ID: 23142137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of β-catenin expression inhibits neuroblastoma cell growth in vitro and in vivo.
    Yao W; Li K; Zheng S; Xiao X; Ma Y; Zhai X
    J Pediatr Surg; 2013 Dec; 48(12):2466-73. PubMed ID: 24314188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.
    Vu T; Datta A; Banister C; Jin L; Yuan G; Samuel T; Bae S; Eltoum IE; Manne U; Zhang B; Welner RS; Mitra K; Buckhaults P; Datta PK
    Gastroenterology; 2022 Jan; 162(1):193-208. PubMed ID: 34520730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.